Over the past six months, Jenoptik has invested around twenty million euros in the new site on “Gross-Berliner Damm” in the Berlin district of Treptow-Koepenick. State-of-the-art space will be available, including more than 1,000 square meters of clean room production space and around 600 square meters of logistics space as well as office and recreation rooms. Additional space of the same size will be held in reserve for future growth.

“We are proud that we now have another location here in Berlin with state-of-the-art equipment and great growth potential in the Jenoptik group. The life science and medical technology market, along with semiconductor and electronics, and smart mobility, is one of the three photonics core markets on which we are focusing our future growth. Our colleagues in Berlin have shown much patience and flexibility over the past few months and have continued to drive the business and expand it. For this, I would like to thank them and the entire team, which completed the project in such a short time and under conditions that were not easy,” said Dr Stefan Traeger, president and CEO of Jenoptik AG at the ribbon cutting ceremony on June 23rd.

In November 2021, Jenoptik completed the acquisition of BG Medical, significantly strengthening its medical technology business. The Berlin-based company has been operating under the Jenoptik brand since the beginning of 2022 and has been integrated into Jenoptik’s Advanced Photonic Solutions division. With its comprehensive expertise and product portfolio covering 3D imaging, laser and dental systems as well as visualization technologies for minimally invasive, robot-assisted surgery, it represents a significant part of the Jenoptik Group’s medical technology business.

Jenoptik specializes in photonic technologies and systems and is a reliable and flexible partner for the development and production of life science and medical technology applications, among others. The focus here is on light sources and imaging systems for analytical applications in the life science sector (DNA sequencing, cell imaging, tissue and blood analysis) and diagnostic applications in medical technology. In addition, laser-based solutions for therapeutic applications are developed in the medical technology area, for example disk lasers for ophthalmology, diode lasers for aesthetic applications, systems for dentistry as well as minimally invasive and robot-assisted surgery.

Semiconductor laser diodes, which are used as the core element of diode lasers in medical applications as well as in materials processing and metrology, are also manufactured in Berlin – at the Jenoptik fab in Berlin’s Adlershof Science and Technology Park in the close vicinity of the new site that has now been completed. With the acquisition of optical metrology specialist Trioptics, headquartered in Wedel near Hamburg, the Jenoptik group added another Berlin location also in Adlershof in 2020. Jenoptik has a total of two hundred employees at its three sites in Berlin, Germany. Revenue from life science & medical technology to be around 25 percent of group revenue in 2025.